Advances in the stool tests in recent years have made them more effective. A newer version called immunochemical FOBT (iFOBT) is supposed to zero in on colon growths better than an older version ...

Ellie Wilcock, battling stage 4 bowel cancer, shares her overlooked early symptoms: persistent left-side abdominal and pelvic pain initially mistaken for a urinary tract infection, unexplained fatigue ...

The iFOBT (immunochemical fecal occult blood test) — also known as the FIT (fecal immunochemical test) — uses special antibodies to test the stool for blood.

“iM2-PK test proved to have significantly higher sensitivity for CRC and colon adenomatous lesions than that of iFOBT and CEA,” the researchers concluded.

According to new survey data commissioned by the Colorectal Cancer Alliance more than half of U.S. adults would rather do ...

The iFOBT, also known as the FIT (fecal immunochemical test), uses special antibodies to test the stool for blood. One advantage of the iFOBT/FIT is that it does not require a restriction in diet ...

Receiver operating characteristics curves of different inflammatory markers and the iFOBT (A) for the detection of advanced adenoma. * a Results pertain to participants with available stool ...

The immunochemical fecal occult blood test (iFOBT) is effective for predicting lesions in the lower intestine but not in the upper gastrointestinal (GI) tract, confirms a study in CMAJ (Canadian ...

Immunochemical fecal occult blood tests are considered superior to the traditional guaiac-based test, but apparently have a limitation in hot weather.

Geneoscopy, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense.

Despite the high incidence and difficulty in detecting it by patients themselves, people rarely take the initiative to do an immunochemical fecal occult blood test (iFOBT), according to statistics.

The inexpensive tests that look for hidden blood in a person's stool are effective for colon cancer screening, a study out Tuesday confirms.